Molecular Typing of IberoAmerican Cryptococcus neoformans Isolates

• Main Authors: Wieland Meyer, Alexandra Castañeda, Stuart Jackson, Matthew Huynh, Elizabeth Castañeda
• Format: Article
• Language: English
• Published: Centers for Disease Control and Prevention 2003-02-01
• Series: Emerging Infectious Diseases
• Subjects: Cryptococcus neoformans; molecular epidemiology; PCR-fingerprinting; URA5 – RFLP analysis; research; Australia
• Online Access: https://wwwnc.cdc.gov/eid/article/9/2/02-0246_article

A network was established to acquire basic knowledge of Cryptococcus neoformans in IberoAmerican countries. To this effect, 340 clinical, veterinary, and environmental isolates from Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, Guatemala, and Spain were typed by using M13 polymerase chain reaction-fingerprinting and orotidine monophosphate pyrophosphorylase (URA5) gene restriction fragment length polymorphsm analysis with HhaI and Sau96I in a double digest. Both techniques grouped all isolates into eight previously established molecular types. The majority of the isolates, 68.2% (n=232), were VNI (var. grubii, serotype A), which accords with the fact that this variety causes most human cryptococcal infections worldwide. A smaller proportion, 5.6% (n=19), were VNII (var. grubii, serotype A); 4.1% (n=14), VNIII (AD hybrid), with 9 isolates having a polymorphism in the URA5 gene; 1.8% (n=6), VNIV (var. neoformans, serotype D); 3.5% (n=12), VGI; 6.2% (n=21), VGII; 9.1% (n=31), VGIII, and 1.5% (n=5) VGIV, with all four VG types containing var. gattii serotypes B and C isolates.